Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
752 |
|
| Actual shortage: | 20 (3%) | |
| Anticipated shortage: | 2 (0%) | |
| Avoided shortage: | 88 (12%) | |
| Resolved: | 642 (85%) | |
Discontinuation Reports |
235 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 235 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
98 (10%) |
|
Overdue reports |
1 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLARUS | 40MG | CAPSULE | Resolved | 2022-01-13 | 2022-04-13 | 152648 |
| CLARUS | 10MG | CAPSULE | Resolved | 2022-06-18 | 2022-09-01 | 163042 |
| CLARUS | 40MG | CAPSULE | Resolved | 2022-06-18 | 2022-09-01 | 163045 |
| CLARUS | 10MG | CAPSULE | Resolved | 2024-07-09 | 2024-09-24 | 232550 |
| CLARUS | 40MG | CAPSULE | Resolved | 2024-07-09 | 2024-09-24 | 232553 |
| CLARUS | 10MG | CAPSULE | Resolved | 2024-10-04 | 2024-11-18 | 239457 |
| CLARUS | 40MG | CAPSULE | Resolved | 2024-10-29 | 2025-03-26 | 241465 |
| CLARUS | 10MG | CAPSULE | Resolved | 2024-12-03 | 2025-01-07 | 244622 |
| CLARUS | 10MG | CAPSULE | Resolved | 2025-01-21 | 2025-03-31 | 248180 |
| CONTINGENCY ONE | 1.5MG | TABLET | Resolved | 2017-11-08 | 2018-05-31 | 28619 |
| CONTINGENCY ONE | 1.5MG | TABLET | Resolved | 2021-01-05 | 2021-02-03 | 130854 |
| CONTINGENCY ONE | 1.5MG | TABLET | Resolved | 2025-01-07 | 2025-02-05 | 246904 |
| ESME 21 | 20MCG 100MCG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51450 |
| ESME 28 | 20MCG 100MCG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51453 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2018-12-05 | 2019-03-06 | 68756 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2019-05-22 | 2019-05-29 | 84512 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2019-06-04 | 2019-06-19 | 85557 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2020-01-28 | 2020-05-06 | 104512 |
| FREYA 21 | 0.03MG 0.15MG | TABLET | Resolved | 2022-10-11 | 2022-10-31 | 171506 |
| FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2017-11-03 | 2019-03-21 | 28041 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-VALSARTAN HCTZ | 25MG 320MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6845 |
| MYLAN-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20259 |
| MYLAN-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20287 |
| MYLAN-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-07-04 | 20306 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51647 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-ZOPICLONE | 5MG | TABLET | Discontinued | 2018-05-04 | 2018-05-04 | 48576 |
| MYLAN-ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51665 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51668 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51671 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51674 |